Skip to main content

Main menu

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • Other Publications
    • abfm

User menu

Search

  • Advanced search
American Board of Family Medicine
  • Other Publications
    • abfm
American Board of Family Medicine

American Board of Family Medicine

Advanced Search

  • HOME
  • ARTICLES
    • Current Issue
    • Ahead of Print
    • Archives
    • Abstracts In Press
    • Special Issue Archive
    • Subject Collections
  • INFO FOR
    • Authors
    • Reviewers
    • Call For Papers
    • Subscribers
    • Advertisers
  • SUBMIT
    • Manuscript
    • Peer Review
  • ABOUT
    • The JABFM
    • The Editing Fellowship
    • Editorial Board
    • Indexing
    • Editors' Blog
  • CLASSIFIEDS
  • JABFM on Bluesky
  • JABFM On Facebook
  • JABFM On Twitter
  • JABFM On YouTube
Research ArticleResearch Letter

Opinions of Primary Care Clinicians and Psychiatrists on Monitoring the Metabolic Effects of Antipsychotics

Christina Mangurian, Aishat Giwa, Erin Brosey, Martha Shumway, James Dilley, Elena Fuentes-Afflick, Eliseo J. Pérez-Stable and Dean Schillinger
The Journal of the American Board of Family Medicine May 2019, 32 (3) 418-423; DOI: https://doi.org/10.3122/jabfm.2019.03.180176
Christina Mangurian
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MD, MAS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aishat Giwa
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MHI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Erin Brosey
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MS
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martha Shumway
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
PhD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Dilley
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Elena Fuentes-Afflick
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MD, MPH
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Eliseo J. Pérez-Stable
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dean Schillinger
From Department of Psychiatry, Weill Institute for Neurosciences, University of California, San Francisco (CM, MS, JD, AG); UCSF Philip R. Lee Institute for Health Policy Studies, University of California, San Francisco (CM); Department of Psychiatry, Northern California Institute of Research and Education, University of California, San Francisco (EB); San Francisco VA Medical Center (EB); Center for Vulnerable Populations, University of California, San Francisco (CM); Department of Pediatrics, University of California, San Francisco (EF-A); National Institute on Minority Health and Health Disparities, National Institute of Health (EJP-S); Division of General Internal Medicine, Department of Medicine, University of California, San Francisco (DS).
MD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure1
    • Download figure
    • Open in new tab
  • Figure2
    • Download figure
    • Open in new tab
  • Figure3
    • Download figure
    • Open in new tab
  • Figure4
    • Download figure
    • Open in new tab
  • Figure5
    • Download figure
    • Open in new tab

Tables

  • Figures
    • View popup
    Table 1.

    Preferences for Type of Clinician Who Should Be Conducting Metabolic Monitoring of People with Severe Mental Illness

    StatementProvider Type*
    PsychiatristsPrimary Care Clinicians
    DisagreeAgreeDisagreeAgree
    N%N%N%N%
    Primary care clinicians should screen not psychiatrists†30701430523310266
    Psychiatrists should screen even if the patient has established primary care‡1020398063409360
    • ↵* Notably, there were minor differences in the number of providers responding to these questions. For example, 47 psychiatrists and 154 primary care clinicians answered the first statement and 49 psychiatrists and 156 primary care clinicians answered the second.

    • ↵† Primary care clinicians were more likely than psychiatrists to agree with this statement (P < .001).

    • ↵‡ Psychiatrists were more likely than primary care clinicians to agree with this statement (P = .011).

PreviousNext
Back to top

In this issue

The Journal of the American Board of Family     Medicine: 32 (3)
The Journal of the American Board of Family Medicine
Vol. 32, Issue 3
May-June 2019
  • Table of Contents
  • Table of Contents (PDF)
  • Cover (PDF)
  • Index by author
  • Back Matter (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on American Board of Family Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Opinions of Primary Care Clinicians and Psychiatrists on Monitoring the Metabolic Effects of Antipsychotics
(Your Name) has sent you a message from American Board of Family Medicine
(Your Name) thought you would like to see the American Board of Family Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
11 + 5 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Opinions of Primary Care Clinicians and Psychiatrists on Monitoring the Metabolic Effects of Antipsychotics
Christina Mangurian, Aishat Giwa, Erin Brosey, Martha Shumway, James Dilley, Elena Fuentes-Afflick, Eliseo J. Pérez-Stable, Dean Schillinger
The Journal of the American Board of Family Medicine May 2019, 32 (3) 418-423; DOI: 10.3122/jabfm.2019.03.180176

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Opinions of Primary Care Clinicians and Psychiatrists on Monitoring the Metabolic Effects of Antipsychotics
Christina Mangurian, Aishat Giwa, Erin Brosey, Martha Shumway, James Dilley, Elena Fuentes-Afflick, Eliseo J. Pérez-Stable, Dean Schillinger
The Journal of the American Board of Family Medicine May 2019, 32 (3) 418-423; DOI: 10.3122/jabfm.2019.03.180176
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • Appendix
    • Notes
    • References
  • Figures & Data
  • References
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Yonder: Parkinsons disease, dietary education, antipsychotic medications, and genomic results
  • Family Medicine: Data Driven Practice with Emphasis on Underserved Patients
  • Google Scholar

More in this TOC Section

  • Timing of Certification Stage Completion Associated with Subsequent Certification Exam Outcomes Among Board-Certified Family Physicians
  • Interpersonal Continuity of Care May Help Delay Progression to Type 2 Diabetes
  • Impact of COVID-19 on Chronic Ambulatory-Care-Sensitive Condition Emergency Department Use Among Older Adults
Show more Research Letter

Similar Articles

Keywords

  • Diabetes Mellitus
  • Logistic Regression
  • Mental Health
  • Mental Disorders
  • Metabolic Diseases
  • Primary Health Care
  • Psychiatry
  • Public Health
  • Surveys and Questionnaires
  • Vulnerable Populations

Navigate

  • Home
  • Current Issue
  • Past Issues

Authors & Reviewers

  • Info For Authors
  • Info For Reviewers
  • Submit A Manuscript/Review

Other Services

  • Get Email Alerts
  • Classifieds
  • Reprints and Permissions

Other Resources

  • Forms
  • Contact Us
  • ABFM News

© 2025 American Board of Family Medicine

Powered by HighWire